Delivery Order SPE2DB25D9320-SPE2DB25FWFAR

Award Date 5/16/25
Potential Completion Date 5/19/25
Potential Value $4.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of XTANDI 80 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD). The $12,508.77 firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which runs through December 31,...
This federal contract award is for the delivery of XTANDI 80 MG TABLET 60S pharmaceutical products to the Medical Supply Chain of the Defense Logistics Agency (DLA). The contract, valued at $4,169.59, is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This federal contract award is for the delivery of XTANDI 40 MG TABLET 120S to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense (DoD). The contract, valued at $4,169.59, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with no set-aside designation, issued under DMS Pharmaceutical Group's larger indefinite delivery...
This federal contract award is for the delivery of XTANDI 40 MG CAPSULE 120S to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $77,604.30, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order, with an ultimate completion date of May 3, 2023. DMS Pharmaceutical Group Inc. holds a significant...
This federal contract award is for the delivery of XTANDI 40 MG TABLET 120S to the Defense Logistics Agency Troop Support Medical. The $61,392.48 firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business organization based in Park Ridge, Illinois. The contract has a completion date of March 1, 2024 and was awarded on February 29, 2024. This award is issued under DMS Pharmaceutical Group's existing indefinite delivery contract...
The federal contract award summarized here is for the delivery of XTANDI 40 MG CAPSULE 120S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order valued at $8,480.94 with a completion date of March 20, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a $4,169.59 firm fixed-price delivery order for the pharmaceutical product XTANDI 40 MG TABLET 120S. The contract has an ultimate completion date of January 15, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, worth up to $4,169.59, is for the delivery of XTANDI 40 MG TABLET 120S, with an ultimate completion date of April 5, 2024. This award is part of a larger indefinite delivery contract, SPE2DB, that DMS Pharmaceutical Group holds with the DLA, valued at...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $4,169.59, is for the supply of XTANDI 40 MG TABLET 120S to the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The contract has an ultimate completion date of September 11, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of the prescription drug XTANDI (80 mg tablet, 60-count) and has an ultimate completion date of October 23, 2024. This award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA valued at...
  • SPE2DB25D9320
    Indefinite Delivery Contract
  • SPE2DB25D9320-SPE2DB25FWFAR
    Delivery Order

This federal contract award is for the delivery of XTANDI 80 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The $4,169.59 firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois.

The contract has an ultimate completion date of May 19, 2025 and was awarded on May 16, 2025. It is not associated with a set-aside program. DMS Pharmaceutical Group Inc. has a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide.

Generated 8/15/25, 9:54 AM